Loading...
₹ 0
0.00%
Loading...
About
Loading... [1]
- Market Cap ₹ 0 Cr.
- Current Price ₹ 0
- High / Low ₹ 0 / 0
- Stock P/E
- Dividend Yield 0 %
- ROE 0 %
- EPS 0
- P/B Ratio 0
- Net Profit Margin 0 %
- Debt to Equity 0
- ROCE 0 %
- Interest Coverage 0 %
Stock News - Hcg
Latest updates related to Hcg
Sr No. | Title | Sentiment |
---|---|---|
1 | Anup Engineering, Healthcare Global Enterprise (HCG) and Dr Lal Path Labs hit 52-week highs: Here’s why Upstox | 🔄 |
2 | KKR set to buy cancer chain HCG The Economic Times | 🔄 |
3 | KKR picks up 54% stake in cancer hospital chain HCG for Rs 3,465 crore Business Standard | 🔄 |
4 | KKR in final talks to acquire controlling stake in HCG; negotiations on over founder’s role Moneycontrol | 🔄 |
5 | KKR Grabs 54% Stake in HCG – How This Billion Dollar Deal Redefines Indian Healthcare Elets | 🔄 |
6 | KKR TO ACQUIRE 54% STAKE IN HCG ICICI Direct | 🔄 |
7 | KKR to buy 54% stake in cancer care chain HCG for $400 million The Financial Express | 🔄 |
8 | Use of hCG for luteal support in natural frozen–thawed blastocyst transfer cycles: a cohort study Frontiers | 🔄 |
9 | HCG uses CyberKnife S7 for Parkinson’s treatment ETHealthWorld | 🔄 |
10 | KKR to buy cancer care hospital chain HCG from CVC for $400 million The Economic Times | 🔄 |
Loading peers table...
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Loading data...
Quarterly Data Visualization
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Loading Profit & Loss data...
Profit & Loss Data Visualization:
Compounded Sales Growth | |
---|---|
10 Years: | |
5 Years: | |
3 Years: | |
TTM: |
Compounded Profit Growth | |
---|---|
10 Years: | |
5 Years: | |
3 Years: | |
TTM: |
Stock Price CAGR | |
---|---|
10 Years: | |
5 Years: | |
3 Years: | |
1 Year: |
Return on Equity | |
---|---|
10 Years: | |
5 Years: | |
3 Years: | |
Last Year: |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Balance Sheet Data Visualization:
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Ratios
Consolidated Figures in Rs. Crores / View Standalone